Was published
Advertising
By 2030, Astrazeneca invested $ 50 billion (42.8 billion euros) in expanding research and growth and its production, the company said on Monday.
This, since the pharmaceutical giant seeks to achieve an goal of $ 80 billion (68.5 billion euros) by 2030, while 50% hopes to come from the United States.
The announcement is also the government of Trump threatens responsibilities up to 200% for drugs produced outside the United States.
A new investment announcement added up to $ 3.5 billion (3 billion euros) promised in November 2024. According to the company’s announcement, the United States play a “critical role” in the ability of Astrazeneca to launch 20 new drugs by the end of the decade.
What will the Astrazeneca produce in the USA?
As part of the investment, the British company plans to build a new cost in Virginia in Virginia. This plant will be focused on the production of methods of treating chronic diseases and is the largest individual investment in the object when the liba conducted by the company.
“(This) The announcement emphasizes our faith in the innovation of America in the field of bioforms and our commitment to millions of patients necessary for our medicines in America and all over the world,” said Pascal Soriot, Executive Director of Astrazeneca.
“I look forward to the opportunity to work with Governor Yankokin and his team to work on the largest investments in separate production, which we did when we did. It reflects the desires of Virginia of the Commonwealth to create high -performance jobs in the field of science and technology and improve the country. ”
Installation in Virginia will pay special attention to the production of substances that make up the ASTRAZENECA portfolio for Weight management And the treatment of metabolism.
In addition to the location of Virginia, investments will contribute to the expansion of objects and production in Massachusetts, Maryland, California, Indiana and Texas, as well as to search for new places for clinical trials.
Astrazeneca already has 19 funds for research and development, production and trade facilities in the USA, and the country is the largest market of the company, which is 42% of its income. Currently, the company has more than 18,000 employees and support 92,000 jobs in all the United States. It is expected that a new investment announcement will create tens of thousands of large jobs in the coming years.